Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
American College of Rheumatology

2. Address

Address1
2200 Lake Boulevard NE
 Address2
​
City
ATLANTA
 State
GA
 Zip Code
30319
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Adam Cooper
​4046333777
​acooper@rheumatology.org
5. Senate ID#
​320873-12
7. Client Name Self Check if client is a state or local government or instrumentality
​American College of Rheumatology
6. House ID#
​395670000
TYPE OF REPORT 8. Year
​2024
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​70,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Adam Cooper
 Date
1/21/2025 6:29:46 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665, HR 4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
H.R.6371 - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Appropriation legislation related to Medicare Physician Payments cuts implemented in 2024
Appropriations legislation related to the Congressionally Directed Medical Research Program
Appropriations legislation related to the National Institutes of Health
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 8702 - Improving Seniors Timely Access to Care Act of 2024
S. 4532 - Improving Seniors Timely Access to Care Act of 2024
H.R. 6664 - The Innovation in Pediatric Drugs Act
S. 4349 - Electronic Prior Authorization for Prescription Drugs Act
HR. 6487 - No Fees for EFTs Act
S. 3805 - No Fees for EFTs Act
S. 4935 - Physician Fee Stabilization Act
H.R. 7623 - Telehealth Modernization Act
S. 3967 - Telehealth Modernization Act
H.R. 7153 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
S. 3679 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
H.R. 6545 - Physician Fee Schedule Update and Improvements Act
H.R. 10545 - American Relief Act of 2025
H.R. 8774 - Department of Defense Appropriations Act, 2025
H.R. 9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Adam
Cooper
​
​
Lennie
McDaniel
​
​
Paige
Colston
​
​
Colby
Tiner
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665, HR 4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
H.R.6371 - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Appropriation legislation related to Medicare Physician Payments cuts implemented in 2024
Appropriations legislation related to the Congressionally Directed Medical Research Program
Appropriations legislation related to the National Institutes of Health
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 8702 - Improving Seniors Timely Access to Care Act of 2024
S. 4532 - Improving Seniors Timely Access to Care Act of 2024
H.R. 6664 - The Innovation in Pediatric Drugs Act
S. 4349 - Electronic Prior Authorization for Prescription Drugs Act
HR. 6487 - No Fees for EFTs Act
S. 3805 - No Fees for EFTs Act
S. 4935 - Physician Fee Stabilization Act
H.R. 7623 - Telehealth Modernization Act
S. 3967 - Telehealth Modernization Act
H.R. 7153 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
S. 3679 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
H.R. 6545 - Physician Fee Schedule Update and Improvements Act
H.R. 10545 - American Relief Act of 2025
H.R. 8774 - Department of Defense Appropriations Act, 2025
H.R. 9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Adam
Cooper
​
​
Lennie
McDaniel
​
​
Paige
Colston
​
​
Colby
Tiner
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Monitor federal issues and legislation associated with health care policy.
Monitor federal and legislative activity related to Medicare reimbursement.
Monitor federal and legislative activity related to drug pricing.
Monitoring and outreach on legislative activity related to the COVID-19 pandemic and the federal governments response.
FY2024 Defense Appropriations Act
Fiscal 2024 Labor-HHS-Education Appropriations
P.L. 116-136, CARES Act
P.L. 113-5 Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA)
S. 127 - Pharmacy Benefit Manager Transparency Act
H.R. 830 - The HELP Copays Act
S. 1375 - HELP Copays Act
H.R. 1202 - Resident Education Deferred Interest Act, or REDI Act
S. 704 - REDI Act
S. 665, HR 4942 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 2389 - Resident Physician Shortage Reduction Act
S. 1302 - Resident Physician Shortage Reduction Act
H.R. 2474 - Strengthening Medicare for Patients and Providers Act
S. 652, H.R. 2630 - Safe Step Act
S. 1339 - Pharmacy Benefit Manager Reform Act
H.R. 2670 - National Defense Authorization Act
H.R. 2816 - Pharmacy Benefit Manager Sunshine and Accountability Act
H.R. 2679 - Pharmacy Benefits Manager Accountability Act
H.R. 2474 - The Strengthening Medicare for Patients and Providers Act
H.R.6371 - Provider Reimbursement Stability Act of 2023
S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act
H.R. 5391 - Protecting Patient Access to Cancer and Complex Therapies Act
Appropriation legislation related to Medicare Physician Payments cuts implemented in 2024
Appropriations legislation related to the Congressionally Directed Medical Research Program
Appropriations legislation related to the National Institutes of Health
S. 705 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 2761 - Specialty Physicians Advancing Rural Care (SPARC) Act
H.R. 8702 - Improving Seniors Timely Access to Care Act of 2024
S. 4532 - Improving Seniors Timely Access to Care Act of 2024
H.R. 6664 - The Innovation in Pediatric Drugs Act
S. 4349 - Electronic Prior Authorization for Prescription Drugs Act
HR. 6487 - No Fees for EFTs Act
S. 3805 - No Fees for EFTs Act
S. 4935 - Physician Fee Stabilization Act
H.R. 7623 - Telehealth Modernization Act
S. 3967 - Telehealth Modernization Act
H.R. 7153 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
S. 3679 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act
H.R. 6545 - Physician Fee Schedule Update and Improvements Act
H.R. 10545 - American Relief Act of 2025
H.R. 8774 - Department of Defense Appropriations Act, 2025
H.R. 9029 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Adam
Cooper
​
​
Lennie
McDaniel
​
​
Paige
Colston
​
​
Colby
Tiner
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)